Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06064617 · ClinicalTrials.gov registry record · NA
Accommodative Behaviors in Multifocal Contact Lenses
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06064617 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 20 participants.
The verdict
NCT06064617, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
Addition lenses are often used to treat a range of eye conditions. Addition lenses are specifically used to help patients who do not have the ability to focus their eyes to see clearly up close. Eye focusing is called accommodation. Addition lenses are easy to prescribe in a pair of glasses and are often called the bifocal portion of the glasses. Addition lenses can be used for adults who have presbyopia (they cannot read up close without the aide of a bifocal) and for patients of all ages who have eye focusing problems (e.g. accommodative insufficiency, accommodative infacility, accommodative dysfunction). Addition powers can also be put into contact lenses. Contact lenses that have addition powers in them are called multifocal contact lenses. These are often marketed for patients that are 40 and over who have presbyopia, and are prescribed to help patients see up close as well as far away in their contact lenses. Multifocal contact lenses are also used in children with nearsightedness because studies have shown that some multifocal designs can slow down the progression of nearsightedness. As stated before, addition lenses can be used to treat eye focusing problems in patients of all ages, before presbyopia. What is unclear is whether the addition power in contact lenses has the same treatment effect as an addition power in a pair of glasses when they are being used to treat eye focusing problems. This study will assess how different kinds of multifocal contact lenses (center distance or center near) will change eye focusing and eye teaming in young adult patients.
Interventions
- DEVICE Center-Near (+2.50D) Coopervision Biofinity Multifocal Contact Lens
- DEVICE Center Distance (+2.50 D) Coopervision Biofinity Multifocal Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-11-01 |
| Est. Completion | 2024-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06064617
The ClinicalTrials.gov registry entry for NCT06064617 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Center-Near (+2.50D) Coopervision Biofinity Multifocal Contact Lens is the first listed.
NCT06064617 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06064617 about?
NCT06064617 is a clinical study titled "Accommodative Behaviors in Multifocal Contact Lenses". Addition lenses are often used to treat a range of eye conditions. Addition lenses are specifically used to help patients who do not have the ability to focus their eyes to see clearly up close. Eye focusing is called accommodation. Addition lenses are easy to prescribe in a pair of glasses and are ...
What is the current status of trial NCT06064617?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2023-11-01. Estimated completion is 2024-04-30.
What interventions are being tested in trial NCT06064617?
The interventions under investigation include: Center-Near (+2.50D) Coopervision Biofinity Multifocal Contact Lens (DEVICE), Center Distance (+2.50 D) Coopervision Biofinity Multifocal Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT06064617?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.